Yale-New Haven achieves Stage 7

Beth Walsh | | Health Exec | EMR/EHR

Yale-New Haven Hospital (YNNH) has attained Stage 7 status from HIMSS Analytics--recognition for use of a complete EMR in an advanced IT setting.

YNHH is the primary teaching hospital for the Yale School of Medicine with 1,541 beds serving patients on campuses including the Yale-New Haven Children's Hospital, Yale-New Haven Psychiatric Hospital and Smilow Cancer Hospital.

The EMR Adoption Model was developed by HIMSS Analytics in 2005 to evaluate the progress of hospitals using integrated EMR systems. Clinics, outpatient centers and physician practices are evaluated for their use of technology. To achieve Stage 7 status, a HIMSS Analytics executive and or chief information officer must make a site visit to confirm their status. Just 3.7 percent of U.S. hospitals in the HIMSS Analytics database have been awarded this distinction as of the second quarter of 2015.

"It was clear from my visit to Yale-New Haven Hospital that they are serious about their mission, vision and values," said John H. Daniels, global vice president of HIMSS Analytics' healthcare advisory services group, in a press statement. "They are leveraging their EHR technology in very innovative ways."

YNHH's achievementsinclude "saving time and improving the patient experience through radiology protocolling using the EHR," said Daniels. "Their eICU has proven its value, particularly when caring for patients in isolation; research recruitment is integrated in the patient portal; and they have proven the value of clinical decision support evidenced by their smoking cessation protocol compliance project."

Yale-New Haven Hospital will be recognized at the 2016 Annual HIMSS Conference & Exhibition, beginning Feb. 29, 2016, in Las Vegas.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Related Content

Christmas ransomware exposed over 300K patient records to dark web
Private equity-backed cardiology group puts cloud-based technology in hands of its cardiologists
AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do
Indiana hospitals reduce nuisance alerts by 77% with medication decision support software
Leveraging machine learning to rapidly create clinical AI algorithms
How medication reconciliation data consolidation in the EHR enables better patient care

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.